Volociximab, a chimeric integrin alpha5beta1 antibody, inhibits the growth of VX2 tumors in rabbits (Q81041067)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17786386%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

Volociximab, a chimeric integrin alpha5beta1 antibody, inhibits the growth of VX2 tumors in rabbits (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17786386%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Vinay Bhaskar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17786386%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Melvin Fox

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17786386%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Danna Breinberg

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17786386%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Melanie H-L Wong

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17786386%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Pauline E Wales

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17786386%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Susan Rhodes

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17786386%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Robert B DuBridge

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17786386%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Vanitha Ramakrishnan

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17786386%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

1 September 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17786386%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

5 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17786386%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17786386%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17786386%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

7-12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17786386%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10637-007-9078-z

5 January 2020

exact match

0 references

cites work

Experiments on the cause of the rabbit carcinomas derived from virus-induced papillomas. II. Loss by the Vx2 carcinoma of the power to immunize hosts against the papilloma virus

1 reference

12 December 2020

Rapid access of antibodies to alpha5beta1 integrin overexpressed on the luminal surface of tumor blood vessels

1 reference

12 December 2020

The small alpha5beta1 integrin antagonist, SJ749, reduces proliferation and clonogenicity of human astrocytoma cells

1 reference

12 December 2020

Integrins, angiogenesis and vascular cell survival

1 reference

12 December 2020

Antitumor effects induced by the combination of TNP-470 as an angiogenesis inhibitor and lentinan as a biological response modifier in a rabbit spontaneous liver metastasis model

1 reference

12 December 2020

Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins

1 reference

12 December 2020

Preclinical evaluation of an anti-alpha5beta1 integrin antibody as a novel anti-angiogenic agent

1 reference

12 December 2020

Integrins: bidirectional, allosteric signaling machines

1 reference

12 December 2020

Fundamental Concepts of the Angiogenic Process

1 reference

12 December 2020

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

1 reference

12 December 2020

1 reference

12 December 2020

Intrathecal 4-hydroperoxycyclophosphamide: neurotoxicity, cerebrospinal fluid pharmacokinetics, and antitumor activity in a rabbit model of VX2 leptomeningeal carcinomatosis

1 reference

12 December 2020

A non-RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis in vivo.

1 reference

12 December 2020

The diverse roles of integrins and their ligands in angiogenesis

1 reference

12 December 2020

alpha5beta1 integrin stimulates Bcl-2 expression and cell survival through Akt, focal adhesion kinase, and Ca2+/calmodulin-dependent protein kinase IV.

1 reference

12 December 2020

Lymphatic chemotherapy induces apoptosis in lymph node metastases in a rabbit breast carcinoma model

1 reference

12 December 2020

Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin

1 reference

12 December 2020

Intra-arterial administration of the angiogenesis inhibitor TNP-470 blocks liver metastasis in a rabbit model

1 reference

12 December 2020

Inhibition of endothelial cell survival and angiogenesis by protein kinase A

1 reference

12 December 2020

A fibronectin fragment inhibits tumor growth, angiogenesis, and metastasis

1 reference

12 December 2020